Successful biosimilar registration in Jordan requires careful preparation and alignment with Jordan Food and Drug Administration (JFDA) requirements. Before submission, manufacturers should ensure that quality, non-clinical, and clinical comparability data are complete and scientifically justified. Regulatory gaps, incomplete documentation, or inconsistencies between the biosimilar and reference product can result in Regulatory queries and approval delays. Use this Pre-Submission Checklist for Biosimilar Registration in Jordan to assess submission readiness and support a smoother biosimilar registration process in Jordan.
Fill the form below to download the Checklist